Home › Funds › BROWN BROTHERS HARRIMAN & CO › JNJ

BROWN BROTHERS HARRIMAN & CO position in JNJ

JOHNSON & JOHNSON · Health Care

BROWN BROTHERS HARRIMAN & CO reported holding 936,115 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$247.8M, representing 1.07% of its reported portfolio and ranking #25 among its reported holdings. BROWN BROTHERS HARRIMAN & CO has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)936.12K sh
Reported value held$247.83M
Portfolio Weight1.07%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How BROWN BROTHERS HARRIMAN & CO's JNJ position evolved

BROWN BROTHERS HARRIMAN & CO first disclosed a stake in JNJ in Q3 2023 at 363,511 shares (US$56.6M). The position peaked in Q3 2026 at 936,115 shares, worth US$247.8M. Across 13 filings, BROWN BROTHERS HARRIMAN & CO increased the stake 6 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 936,115 shares valued at US$247.8M — a reduction of -17,452 shares quarter over quarter.. Notable position changes include a 60% increase in Q1 2026 (shares rose 4% over the following quarter), a 59% increase in Q2 2026 (shares rose 4% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 363.51K $56.62M New
Q4 2023 384.78K $60.31M Add
Q1 2024 381.60K $60.37M Reduce
Q2 2024 373.25K $54.55M Reduce
Q3 2024 364.63K $59.09M Reduce
Q4 2024 355.50K $51.41M Reduce
Q1 2025 351.46K $58.29M Reduce
Q2 2025 366.27K $55.95M Add
Q3 2025 374.94K $69.52M Add
Q4 2025 376.91K $78.00M Add
Q1 2026 601.32K $146.99M Add
Q2 2026 953.57K $242.18M Add
Q3 2026 936.12K $247.83M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 32 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$41.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has BROWN BROTHERS HARRIMAN & CO held JNJ?

BROWN BROTHERS HARRIMAN & CO has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is BROWN BROTHERS HARRIMAN & CO's current position in JNJ?

As of Q3 2026, BROWN BROTHERS HARRIMAN & CO holds 936.12K shares of JNJ (JOHNSON & JOHNSON), valued at $247.83M, representing 1.07% of its reported portfolio and ranking #25.

Has BROWN BROTHERS HARRIMAN & CO been buying or selling JNJ?

In the latest 13F filing (Q3 2026), BROWN BROTHERS HARRIMAN & CO reduced its position in JNJ. The position peaked in Q3 2026 at 936.12K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.